Flushing  >>  niacin extended-release formulation  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
niacin extended-release formulation / Generic mfg.
ASA EFFECTS, NCT00626392: Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia

Completed
3
277
US
niacin extended-release (NER), Niaspan, aspirin (ASA), acetylsalicylic acid, aspirin placebo (ASA Pbo), placebo
Abbott
Dyslipidemia
04/08
04/08
NCT00630877: Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

Completed
3
276
US
Niacin extended-release (NER), ABT-919, Niaspan, Niacin extended-release (NER) placebo, Aspirin (ASA), acetylsalicylic acid, Aspirin (ASA) placebo
Abbott
Dyslipidemia
06/08
06/08

Download Options